These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26352072)

  • 1. Increased levels of serum clusterin is associated with intrauterine growth restriction and adverse pregnancy outcomes in preeclampsia.
    Oztas E; Ozler S; Ersoy AO; Iskender CT; Sucak A; Ergin M; Uygur D; Danisman N
    J Perinat Med; 2016 Apr; 44(3):269-75. PubMed ID: 26352072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
    Laskowska M; Laskowska K; Oleszczuk J
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can maternal serum placental growth factor estimation in early second trimester predict the occurrence of early onset preeclampsia and/or early onset intrauterine growth restriction? A prospective cohort study.
    Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
    J Obstet Gynaecol Res; 2013 May; 39(5):881-90. PubMed ID: 23496304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.
    Chafetz I; Kuhnreich I; Sammar M; Tal Y; Gibor Y; Meiri H; Cuckle H; Wolf M
    Am J Obstet Gynecol; 2007 Jul; 197(1):35.e1-7. PubMed ID: 17618748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia.
    Papadopoulou E; Sifakis S; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
    Growth Horm IGF Res; 2006; 16(5-6):290-6. PubMed ID: 16996762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation.
    Wathén KA; Ylikorkala O; Andersson S; Alfthan H; Stenman UH; Vuorela P
    Acta Obstet Gynecol Scand; 2009; 88(5):593-8. PubMed ID: 19308751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
    Wathén KA; Tuutti E; Stenman UH; Alfthan H; Halmesmäki E; Finne P; Ylikorkala O; Vuorela P
    J Clin Endocrinol Metab; 2006 Jan; 91(1):180-4. PubMed ID: 16263826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining 2nd-trimester maternal serum homocysteine levels and uterine artery Doppler for prediction of preeclampsia and isolated intrauterine growth restriction.
    Onalan R; Onalan G; Gunenc Z; Karabulut E
    Gynecol Obstet Invest; 2006; 61(3):142-8. PubMed ID: 16374017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation of maternal serum eNOS, NOSTRIN and ADMA levels with aetiopathogenesis of preeclampsia and/or intrauterine fetal growth restriction.
    Laskowska M; Laskowska K; Oleszczuk J
    J Matern Fetal Neonatal Med; 2015 Jan; 28(1):26-32. PubMed ID: 24588201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of serum serglycin and agrin is associated with adverse perinatal outcome in early onset preeclampsia.
    Gumus Guler B; Ozler S
    Fetal Pediatr Pathol; 2019 Oct; 38(5):418-431. PubMed ID: 31018746
    [No Abstract]   [Full Text] [Related]  

  • 11. Asymmetric dimethylarginine in normotensive pregnant women with isolated fetal intrauterine growth restriction: a comparison with preeclamptic women with and without intrauterine growth restriction.
    Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
    J Matern Fetal Neonatal Med; 2011 Jul; 24(7):936-42. PubMed ID: 21142768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of endothelial dysfunction in preeclampsia and neonatal morbidity: a case-control study.
    Masoura S; Kalogiannidis I; Makedou K; Theodoridis T; Koiou K; Gerou S; Athanasiadis A; Agorastos T
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():119-23. PubMed ID: 24485669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. May maternal anti-mullerian hormone levels predict adverse maternal and perinatal outcomes in preeclampsia?
    Tokmak A; Güney G; Aksoy RT; Guzel AI; Topcu HO; Keçecioğlu TS; Uygur D
    J Matern Fetal Neonatal Med; 2015 Aug; 28(12):1451-6. PubMed ID: 25133554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic profiling reveals α1-antitrypsin, α1-microglobulin, and clusterin as preeclampsia-related serum proteins in pregnant women.
    Hsu TY; Hsieh TT; Yang KD; Tsai CC; Ou CY; Cheng BH; Wong YH; Hung HN; Chou AK; Hsiao CC; Lin H
    Taiwan J Obstet Gynecol; 2015 Oct; 54(5):499-504. PubMed ID: 26522099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible role of asymmetric dimethylarginine (ADMA) in prediction of perinatal outcome in preeclampsia and fetal growth retardation related to preeclampsia.
    Gumus E; Atalay MA; Cetinkaya Demir B; Sahin Gunes E
    J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3806-11. PubMed ID: 26821682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of maternal and umbilical serum TNFalpha levels in preeclamptic pregnancies in the intrauterine normal and growth-restricted fetus.
    Laskowska M; Leszczyńska-Gorzelak B; Laskowska K; Oleszczuk J
    J Matern Fetal Neonatal Med; 2006 Jun; 19(6):347-51. PubMed ID: 16801311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?
    Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
    Arch Gynecol Obstet; 2013 May; 287(5):865-73. PubMed ID: 23224699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation.
    Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
    J Matern Fetal Neonatal Med; 2007 Jul; 20(7):527-32. PubMed ID: 17674266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Cardiovascular Disease Risk Factors Measured in the First-Trimester on the Severity of Preeclampsia.
    Cheng PJ; Huang SY; Su SY; Hsiao CH; Peng HH; Duan T
    Medicine (Baltimore); 2016 Feb; 95(5):e2653. PubMed ID: 26844488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are the maternal and umbilical VEGF-A and SVEGF-R1 altered in pregnancies complicated by preeclampsia with or without intrauterine foetal growth retardation? Preliminary communication.
    Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
    Med Wieku Rozwoj; 2008; 12(1):499-506. PubMed ID: 18663270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.